The IPO Buzz: Boundless Bio Prices IPO at $16.00 Mid-Point – Stock Falls in NASDAQ Debut
Boundless Bio (BOLD) priced its IPO at $16.00 – the mid-point of its range – on just 6.25 million shares – the number of shares in the prospectus – to raise $100.0 million on Wednesday night, March 27, 2024. The Phase 1/Phase 2 cancer biotech’s stock slid 10.94 percent to open at $14.25 - down $1.75 from its IPO price - at 1:03 p.m. EDT today – Thursday, March 28, 2024 – on the NAS..
Read more March 28, 2024IPO Calendar
Company | Symbol proposed | Shares (Millions) | Est. $ Volume | Expected to Trade | SCOOP Rating | Rating Change |
---|---|---|---|---|---|---|
Alta Global Group Limited | MMA | 1.3 | $ 6.5 mil | 3/28/2024 Priced | S/O | S/O |
Boundless Bio, Inc. | BOLD | 6.3 | $ 100.0 mil | 3/28/2024 Priced | S/O | S/O |
Mobile-health Network Solutions | MNDR | 2.3 | $ 10.1 mil | 3/28/2024 Thursday | S/O | S/O |
Last 100 IPOs - March 27, 2024
Number of IPOs priced : | 100 |
Number Up: | 34 |
Number Down: | 66 |
Number Unchanged: | 0 |
Percentage Change From Issue Price: | 9.20% |
Percentage Change for The Nasdaq Composite | 20.36% |
2024 IPO Scorecard - March 27, 2024
Number of IPOs priced (Excluding 6 units) : | 35 |
Number Up: | 15 |
Number Down: | 20 |
Number Unchanged: | 0 |
Total Return From Issue Price: | 21.14% |
The Nasdaq Composite Index YTD % Change | 8.69% |